Main Article Content
Cardiovascular diseases (CVD) are now the number one cause of death in low- and middle-income countries, including those in Central Asia (CA). Low- and middle- income countries (LMICs) bear a disproportionate and growing burden of CVD, which constitutes a challenge to national development. CVD account for more than 43% of cases of disability and 9.0% of cases of temporary disability in many developing countries. The high burden of CVD oftentimes results from insufficient preventive care and a lack of education about the prevention and treatment of these diseases. The rapidly growing burden of CVD and other major non-communicable diseases (NCDs) is a global public health threat, especially in Central Asia. Information on cardiovascular risk factors, including hypertension, diabetes, tobacco use, and alcohol use, is traditionally obtained from studies conducted in Europe and North America, which limits our understanding of these factors in Central Asia. In this review, we collected all published information on CVD in Central Asia from 2000 to 2015, which included the websites of the Ministries of Health, the World Health Organization, PubMed, and other published sources.This narrative review describes CVD burden, stroke incidence, and common CVD risk factors in the five post-Soviet countries of Central Asia (Kazakshstan, Kyrgyzstan, Tajikistan, Turkmenistan, and Uzbekistan).
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site;
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Revised 7/16/2018. Revision Description: Removed outdated link.
Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383(9913):245-254.
Feigin VL, Krishnamurthi RV, Parmar P, et al. Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study. Neuroepidemiology. 2015;45(3):161-176.
Yusuf S RS, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104(22):2746-2753.
World Health Organization. World Health Statistics 2009. http://www.who.int/whosis/whostat/2009/en/. Accessed 11 June, 2018.
Starr SF. Lost Enlightenment: Central Asia's Golden Age from the Arab Conquest to Tamerlane. 2015.
Health of the population of the Republic of Kazakhstan and the activities of health organizations in 2014. Ministry of Health of the Republic of Kazakhstan;2015.
Aringazina A. Development and sustainability: The Challenge of Social Change. London: ZED Books Ltd.; 2016.
Health of population and health care in the Republic of Kazakhstan in 2013. 2013; www.medinfo.kz. Accessed 11 June, 2018.
State Program on Health Systems' Development for the years 2011 - 2015. Ministry of Health of the Republic of Kazakhstan;2010.
Order of the Ministry of Health #145. Ministry of Health of the Republic of Kazakhstan; 2011.
Order of the Ministry of Health #704. Ministry of Health of the Republic of Kazakhstan; 2010.
Basic indicators of population health and activity of health organizations of the Republic of Kazakhstan from 2000 to the present. http://www.medinfo.kz/#/dpsraion. Accessed 11 June, 2018.
Report on the Global Tobacco Epidemic, 2013. World Health Organization;2013.
Law of the Republic of Kazakhstan on Ratification of the WHO Framework Convention on Tobacco Control. 2006.
Decision No. 6 of the Chief Sanitary Doctor: "On the introduction of a ban on smoking hookah in public places.". Ministry of Health of the Republic of Kazakhstan; 2013.
Organization WH. Global status report on alcohol and health 2014. Geneva2014.
State Programme "Densaulyk" for Health Care System Development in Republic of Kazakhstan 2016 - 2019. 2016.
V.V. Benberin VYD, A.K. Kaptagaeva, Т.А. Voshchenkova, Т.Т. Kulkhan Brain stroke as the cause of death in the Republic of Kazakhstan: some risk management factors. The journal of neuroscience of bm Mankovskyi. 2016;4(1).
Jill Farrington FRP, Alexei Yakovlev, Oxana Rotar. Review of acute care and rehabilitation services for heart attack and stroke in Kyrgyzstan. World Health Organization;2017.
National Statistics Data 2015. Bishkek: Centre for Medical Information, 2015.
Institute of Health Metrics and Evaluation. Kyrgyzstan. http://www.healthdata.org/kyrgyzstan. Accessed 11 June, 2018.
Mid-term Review Report of Den Sooluk National Health Reform Program of the Kyrgyz Republic for 2012-2016 Bishkek2016.
M Jakab LH, B Loring, J Tello, T Egruder, M Kontas. Better noncommunicable disease outcomes: challenges and opportunities for health systems. Kyrgyzstan country assessment. Copenhagen: World Health Organization;2014.
Aida Abdraimova AI, Aida Zurdinova Reasons for low health care seeking among men with hypertension in Kyrgyzstan. Bishkek: World Health Organization;2016.
World Bank. Kyrgyz Republic. https://data.worldbank.org/country/kyrgyz-republic.
Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study. The Lancet. 2015;385(9963):117-171.
Community Action for Health. http://www.cah.kg. Accessed 11 June, 2018.
T Schuth ea. The Community Action for Health programme in the Kyrgyz Republic. Swiss Red Cross;2014.
Kyrgyzstan STEPS survey 2013: fact sheet. World Health Organization;2015.
Anderson I BM, Obermann K, Temirov A, Ibragimova G. Independent review of Den Sooluk and project in support of the mid-term review. World Health Organization;2016.
Non-Communicable Disease Country Profile: Tajikistan. World Health Organization;2011.
Tajikistan Demographic and Health Survey Statistical Agency under the President of the Republic of Tajikistan;2012.
Baktygul Akkazieva JT, Barton Smith, Melitta Jakab, Konstantin Krasovsky,Nina Sautenkova, Lola Yuldasheva, Mekhri Shoismatuloeva. Better non-communicable disease outcomes: challenges and opportunities for health systems. World Health Organization;2015.
Baktygul Akkazieva JT, Barton Smith, Melitta Jakab, Konstantin Krasovsky,Nina Sautenkova, Lola Yuldasheva, Mekhri Shoismatuloeva, et al. Improving indicators for noncommunicable diseases: barriers and opportunities for health systems. World Health Organization.
Rose G. Sick individuals and sick populations. International Journal of Epidemiology. 2001;30(3):427-432.
Law on Restriction of the Use of Tobacco Products. Dushanbe: Government of the Republic of Tajikistan; 2011.
WHO Framework Convention on Tobacco Control. World Health Organization;2003.
Rural population survey (2009-2010). State Statistical Agency under the President of the Republic of Tajikistan;2011.
Framework Convention on Tobacco Control. Dushanbe: The Government of the Republic of Tajikistan; 2013.
Health of the population and the effectiveness of the work of medical institutions in the Republic of Tajikistan Republican Center for Medical Statistics and Information;2013.
Global Youth Survey on the Use of Tobacco Products Republic of Tajikistan. World Health Organization;2014.
O Smith SN. Improving the situation: The results of the health system in Europe and Central Asia. The World Bank;2013.
List of vital medicines. World Health Organization;2014.
National Development Strategy of the Republic of Tajikistan for 2005-2015. Government of Republic of Tajikistan;2005.
Strategy of health financing for 2005-2015. Government of Republic of Tajikistan;2005.
National Health Strategy of the Republic of Tajikistan for 2010-2020. The Government of the Republic of Tajikistan;2010.
Babadzhanov AS, Rustamova H. Y., Stozharova N. K., Eshboeva K. U. Retrospective analysis of the incidence of the population of Uzbekistan Bulletin of the Tashkent Medical Academy. 2011(3):97-100.
Stozharova N.K. MMD, Sadullaeva K.A., Sharipova S.A. Analysis of prevalence of the cardiovascular diseases in the population of Uzbekistan. Young Scientist. 2015;90(10).
Zhaldasov A. Evaluation of experimental results in urban experimental PHC facilities Tashkent: Center for Social and Marketing Research;2010.
Uzbekistan Health Examination Survey 2002. 2002.
Uzbekistan STEPS survey 2014. World Health Organization;2014.
WHO report on the global tobacco epidemic. World Health Organization;2015.
Tobacco control database for the WHO European Region 2016; http://data.euro.who.int/tobacco/. Accessed 27 December, 2016.
Urban population survey (1998-2003). Dushanbe: State Statistical Agency under the President of the Republic of Tajikistan 2011.
Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 2009;373(9682):2223-2233.
Holmes MV, Dale CE, Zuccolo L, et al. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ : British Medical Journal. 2014;349.